Showing results (191-200 of 425) with videos related to
Sort By:
Pageof 43
Blood|November 19, 2005
A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translationMario Notari, Paolo Neviani, Ramasamy Santhanam, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 15, 2010
PRDM1/Blimp-1 controls effector cytokine production in human NK cellsMatthew A Smith, Michelle Maurin, Hyun Il Cho, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 5, 2008
TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cellsRossana Trotta, Jessica Dal Col, Jianhua Yu, et al.Science Immunology|May 31, 2024
The tumor-intrinsic role of the m6A reader YTHDF2 in regulating immune evasionSai Xiao, Shoubao Ma, Baofa Sun, et al.Blood|October 16, 2004
Anti-human CTLA-4 monoclonal antibody promotes T-cell expansion and immunity in a hu-PBL-SCID model: a new method for preclinical screening of costimulatory monoclonal antibodiesKenneth F May, Sameek Roychowdhury, Darshna Bhatt, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2021
Targeting Fc Receptor-Mediated Effects and the "Don't Eat Me" Signal with an Oncolytic Virus Expressing an Anti-CD47 Antibody to Treat Metastatic Ovarian CancerLei Tian, Bo Xu, Kun-Yu Teng, et al.Blood|June 8, 2006
Trans-presentation of donor-derived interleukin 15 is necessary for the rapid onset of acute graft-versus-host disease but not for graft-versus-tumor activityBradley W Blaser, Noah R Schwind, Seth Karol, et al.Nature Communications|October 9, 2021
An oncolytic virus expressing a full-length antibody enhances antitumor innate immune response to glioblastomaBo Xu, Lei Tian, Jing Chen, et al.Blood|October 4, 2012
A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myelomaDon M Benson, Craig C Hofmeister, Swaminathan Padmanabhan, et al.Nature Cancer|November 10, 2022
Specific targeting of glioblastoma with an oncolytic virus expressing a cetuximab-CCL5 fusion protein via innate and adaptive immunityLei Tian, Bo Xu, Yuqing Chen, et al.Pageof 43